Definitive Healthcare reported second-quarter revenue of $60.8 million, a 5% decrease year-over-year, but exceeded its guidance. The company achieved a net loss of $(9.3) million, a significant improvement from the prior year's $(306.2) million loss which included substantial goodwill impairment. Adjusted Net Income was $9.7 million and Adjusted EBITDA was $18.7 million, representing a 31% margin. Cash Flow from Operations was $9.3 million, and Unlevered Free Cash Flow was $11.5 million.

Definitive Healthcare reported Q1 2025 financial results with revenue exceeding guidance, despite a 7% decrease year-over-year. The company posted a significant net loss due to goodwill impairment charges but achieved positive unlevered free cash flow.

Definitive Healthcare reported Q4 2024 revenue of $62.3 million, a 6% decrease from Q4 2023. The company experienced a net loss of $(84.7) million, significantly impacted by goodwill impairment charges of $97.1 million. Despite the net loss, adjusted net income increased to $12.6 million and adjusted EBITDA was $17.5 million, representing 28% of revenue.

Definitive Healthcare reported a revenue of $62.7 million, a decrease of 4% compared to Q3 2023. The company's financial performance exceeded the high end of its guidance on revenue, adjusted net income, and adjusted EBITDA. A stock repurchase program of up to $100 million was authorized.

Definitive Healthcare reported a 5% year-over-year increase in revenue, reaching $63.7 million for the second quarter of fiscal year 2024. The company's adjusted EBITDA increased by 21% to $20.9 million, representing 33% of revenue. However, the company experienced a net loss of $(306.2) million, which included goodwill impairment charges of $363.6 million.

Definitive Healthcare reported a 7% year-over-year increase in revenue to $63.5 million for Q1 2024. The company's net loss was $(12.7) million, but adjusted EBITDA was $20.0 million, representing 32% of revenue. The company grew its enterprise customer base by 6% year-over-year, ending the quarter with 559 enterprise customers.

Definitive Healthcare reported Q4 2023 financial results, highlighting a 9% year-over-year increase in revenue to $65.9 million. The company's net loss was $13.4 million, while adjusted EBITDA reached $19.8 million, representing 30% of revenue.

Definitive Healthcare reported a 14% year-over-year increase in revenue, reaching $65.3 million for Q3 2023. The company's adjusted EBITDA was $21.7 million, representing 33% of revenue, compared to $16.4 million in Q3 2022.

Definitive Healthcare reported Q2 2023 financial results with revenue of $61.0 million, a 12% increase year-over-year. The company's adjusted EBITDA was $17.2 million, representing 28% of revenue. The company is issuing financial guidance for Q3 2023 and full year 2023.

Definitive Healthcare reported a solid start to 2023 with an 18% increase in revenue compared to Q1 2022, reaching $59.2 million. The company experienced a net loss of $15.6 million, while adjusted EBITDA stood at $15.7 million, representing 26% of revenue. Customer wins and product innovations were also highlighted.

Definitive Healthcare reported a 31% increase in revenue for Q4 2022, reaching $60.6 million, along with a GAAP net income of $6.7 million compared to a net loss of $(14.8) million in Q4 2021. The company's adjusted EBITDA also increased to $17.0 million, representing 28% of revenue.

Definitive Healthcare reported a strong Q3 2022 with revenue increasing by 33% year-over-year to $57.4 million. The company's adjusted EBITDA was $16.4 million, representing 29% of revenue, and they experienced key customer wins and product innovations.

Definitive Healthcare reported strong second-quarter results with a 37% year-over-year revenue increase to $54.5 million. The company also demonstrated the leverage of its business model with adjusted EBITDA.

Definitive Healthcare reported a 36% year-over-year increase in revenue, reaching $50.1 million for the first quarter of 2022. The company continued to grow its enterprise client base and achieved significant customer wins while also focusing on product innovation with the launch of the Passport Analytics Suite and Latitude Discovery.

Definitive Healthcare reported a 38% year-over-year increase in revenue for the fourth quarter of 2021, reaching $46.3 million. The company's GAAP net loss was $(14.8) million, while adjusted EBITDA was $13.1 million. Full year revenue grew 40% to $166.2 million.

Definitive Healthcare reported a strong third quarter with a 43% increase in revenue compared to the previous year. The company's GAAP net loss was $(21.0) million, and adjusted EBITDA was $14.4 million.